Patient’s name: Daisy Legaspi Right patient Dx: Chronic Hypertension with superimposed Pre-eclampsia Generic Name (Brand

Name) Generic: Ferrous Sulfate 325 mg, Ferrous Sulfate  Therapeutic: Antianemic component in the formation of  Pharmacolog Brand name: Appebon The client was given FESO4 325mg, OD, PO Right dose Right route Right time http://www.mim g/info/ferroussul hemoglobin, myoglobin and enzymes. It is necessary for effective erythropoiesis and transport or utilization of oxygen. ic: Iron supplements Iron status and body iron are sometimes decreased in physiologic al pregnancie s, and have to be monitored because women may need an iron supplemen  Hemochromatosis , hemosiderosis, or other evidence of iron overload;  Anemias not due to iron deficiency;  Some products contain alcohol, tartrazine, or sulfites and should be avoided in patients with known intolerance or hypersensitivity.  Use Cautiously in:  Mild, transient nausea  Heartburn  Anorexia  Constipation  Diarrhea ADVERSE EFFECTS  Large doses may aggravate peptic ulcer, regional enteritis, and ulcerative
 Store all forms at room

Dosage and Frequency





Side Effects

Nursing Responsibilities

PO, Once a is an essential day

 Give between meals

with water but may give with meals if gastrointestinal discomfort occurs.
 Transient staining of

mucous membranes and teeth will occur with liquid iron preparation. To avoid, place liquid on the back of the tongue with dropper or use straw.
 Avoid simultaneous

 Monitor serum iron. and ferritin.  Do not crush sustained- release preparations.  Severe renal impairment (oral products)  Pre-existing cardiovascular disease  Signifiant allergies or asthma  Rheumatoid arthritis  OB: Pregnancy or lactation ( safety of some parenteral products not established) : colitis. record of relief of symptoms (fatigue. paresthesia. pallor.  Eggs and milk inhibit abdomin al pain  Diarrhea  Dehydra absorption.  Severe Iron Poisoning:  Vomiting  Severe administration of antacids or tetracycline. total iron-binding capacity.  Monitor daily pattern of tion  Hyperve ntilation  Pallor or bowel activity and stool consistency.fate/ tation.  Severe hepatic impairment. reticulocyte count. scular collapse . and headache). Ulcerative colitis or regional enteritis  Alcoholism. hemoglobin. irritability.  Assess for clinical cyanosis  Cardiova improvement.  Right medica tion  Right Patient PO: Peptic ulcer.

. Pedi: Safety not established for infants < 4 mo or children < 6 yr.

Sign up to vote on this title
UsefulNot useful